I have to say that the listing decisions that are being made by various plans, whether they are private or public in Canada, create pressure on other plans to move. Greater alignment and collaboration among the plans has already proven to be more effective. I think it helps to improve the service to clients, because they can anticipate what service will be available and get some alignment between coverage. Second, it creates an opportunity for negotiating rebates and cost-saving measures. We already do that, and we see the benefit of having this kind of collaborative approach and of having something that is synchronized.
Often public plans are under pressure to cover some products, because private plans will start to pay for these products right after Health Canada has approved them in the Canadian market. However—as we and our colleagues from VAC mentioned—we normally follow this common drug review process, so we come after. But when a large portion of Canadians have received coverage from their private plan for a drug, you have the physicians starting to prescribe it because it's covered by some, and some plans will start to cover it, as well.
Better alignment there helps to create economy, for sure, and there is already work under way to try to get some alignment into the coverage.